SCHEMBL6506138

SCHEMBL6506138

Cc1ccc(-c2nc(O)cc(C(C)C)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ADORA3 P0DMS8 3/20 0.39
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 2/20 0.36
PTBP1 P26599 1/20 0.36
CYP2C19 P33261 1/20 0.36
TNFSF10 P50591 1/20 0.36
ADORA1 P30542 1/20 0.36
XBP1 P17861 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PTGS2 P35354 1/20 0.35
TRPA1 O75762 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6497749 0.85 NPC1 (0.42) MEN1KMT2AADORA3NPC1RAB9A
SCHEMBL19718861 0.84 MEN1 (0.44) MEN1KMT2AADORA3LMNAADORA1
SCHEMBL2118292 0.83 MEN1 (0.47) MEN1KMT2AADORA3NPC1RAB9A
SCHEMBL6495791 0.81 MKNK1 (0.42) NPC1RAB9A
SCHEMBL6495509 0.79 LMNA (0.46) MEN1KMT2AADORA3NOS3NOS1
SCHEMBL10968094 0.78 NPC1 (0.46) MEN1KMT2AADORA3NPC1RAB9A
SCHEMBL4808706 0.76 CNR1 (0.38) NOS3NOS1NOS2CYP1A2CYP2C19
SCHEMBL10968230 0.72 MEN1 (0.61) MEN1KMT2AADORA3NPC1RAB9A
SCHEMBL11547726 0.71 NOS3 (0.42) NOS3NOS1NOS2LMNACYP2C19
SCHEMBL29325032 0.71 RAB9A (0.50) ADORA3NPC1RAB9AHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844347-B1 Cyclic guanosine monophosphate modulators; cardiovascular diseases; guanylate cyclase activation AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-01-18 US disclosed
EP-1112266-B1 SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, THEIR PRODUCTION AND USE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME AVENTIS PHARMA GMBH (DE) 2003-05-14 EP disclosed
EP-1112266-A1 SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, THEIR PRODUCTION AND USE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME Aventis Pharma Deutschland GmbH (DE) 2001-07-04 EP disclosed
WO-2000009496-A1 SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, THEIR PRODUCTION AND USE AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-02-24 WO disclosed